GlassScriptPhysician profile
Howard M Wilson
NPI 1578590162
$1,438.31
in general payments reported to CMS, 2019-2025
19 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $142 · 2021: $255 · 2022: $133 · 2023: $294 · 2024: $311 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $270.37 | 2020-2025 | Farxiga, Breztri |
| Exact Sciences Corporation | $245.07 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $241.30 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $103.50 | 2021-2025 | |
| Idorsia Pharmaceuticals US INC | $77.35 | 2023 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $74.68 | 2023-2024 | |
| Glaxosmithkline, LLC. | $73.83 | 2020-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Abbott Laboratories | $57.38 | 2021-2024 | Freestyle Libre 3 |
| Biotronik Nro, INC. | $51.09 | 2025 | |
| Alexion Pharmaceuticals, INC. | $45.19 | 2020-2024 | Strensiq |
| Kowa Pharmaceuticals America, INC. | $38.14 | 2021-2022 | |
| Allergan, INC. | $29.06 | 2020 | |
| Bausch Health US, LLC | $25.35 | 2021 | |
| Dexcom, INC. | $24.60 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $20.42 | 2025 | Veozah |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.31 | 2025 | Repatha |
| Sanofi Pasteur INC. | $15.34 | 2023 | |
| Lilly USA, LLC | $15.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.